comparemela.com

Latest Breaking News On - Hememics biotechnologies inc - Page 1 : comparemela.com

Point-of-Care Diagnostic Devices Development

This article describes how general graphene develops highly sensitive and fast point-of-care diagnostic devices by using graphene.

Graphene corporationsepMaria osipovaGraphene biosensorsFast diagnostic devices developmentHememics biotechnologies incGraphene corporationGeneral graphene corporationsepPoint of care diagnostic devices developmentGeneral grapheneHememics biotechnologiesHighly sensitiveAst point of care diagnostic devices

Maryland Organizations and Leaders Drive Progress, Inclusivity, and Community Impact

BALTIMORE (PRWEB) July 19, 2023 The Maryland Marketing Partnership, which helps drive Maryland’s branding and marketing efforts to attract businesses,

National harborUnited statesSouth koreaAnne arundel countyKennedy krieger instituteTim odonaldBlackpoint cyberKarthik sridharanToby bozzutoTom rifordKaiser permanenteTradepoint atlanticGreta gerwigTradepoint atlantic empowerment academyCourtesy of the maryland marketing partnershipColgate university board of trustees

Hememics Biotechnologies, Inc and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors

/PRNewswire/ Hememics Biotechnologies, Inc. has entered into a strategic partnership with General Graphene Corporation of Knoxville Tennessee, the.

Greg ericksonJohn wardenGraphene corporation of knoxville tennesseeGraphene corporationHememics biotechnologies incPrnewswire hememics biotechnologies incGeneral graphene corporationKnoxville tennesseeGeneral grapheneSri aithalHememics biotechnologies

Hememics Biotechnologies, Inc Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth

/PRNewswire/ Hememics Biotechnologies, Inc., developer of first-in-class, handheld, multiplexed biosensor platform that can test antibodies, antigens and.

Prnewswire hememics biotechnologies incMaryland technology development corporationHememics biotechnologies incJohn wardenHememics biotechnologies

Hememics Biotechnologies closes $2M in Seed 2 Financing

Gaithersburg-based Hememics Biotechnologies Inc. announced the closing of a $2 million Seed 2 financing round.

United statesMaryland technology development corporationHememics biotechnologies incMaryland technology development

vimarsana © 2020. All Rights Reserved.